{"transactions":[{"id":674680,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-26T22:13:19.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":2900026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the total number of shares subject to the option will vest upon FDA approval of seralutinib, and 1/24th of the remaining 50% of the total number of shares subject to the option will vest on the last day of each one-month period after such FDA approval, in each case subject to the Reporting Person's continuous service to the Issuer on each such vesting date. To the extent FDA approval of seralutinib does not occur on or prior to the date that is two years following the grant date of the option, 1/24th of the total number of shares subject to the option will vest on the last day of each one-month period following the date that is two years following the grant date of the option, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":2900026,"derivative":{"exercise_price":0.175,"expiration_date":"2036-08-23","underlying":"Common Stock","underlying_shares":2900026},"source":{"system":"sec-edgar","filing":"0001553179-26-000005","document":"wk-form4_1787782397.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000005/wk-form4_1787782397.xml","form_type":"4"}},{"id":832040,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":70000,"derivative":{"exercise_price":0.45,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832039,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":47667,"derivative":{"exercise_price":0.45,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832038,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832037,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":126667,"derivative":{"exercise_price":0.45,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832036,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":157500,"derivative":{"exercise_price":0.45,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832035,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":157500,"derivative":{"exercise_price":0.45,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832034,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.45,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832033,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":375000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":375000,"derivative":{"exercise_price":0.45,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832032,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":440000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":440000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832031,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":506250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":506250,"derivative":{"exercise_price":0.45,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":506250},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832030,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832029,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832028,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832027,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832026,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832025,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832024,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832023,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":375000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832022,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":440000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":832021,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:14:30.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":506250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":506250},"source":{"system":"sec-edgar","filing":"0001553179-26-000004","document":"wk-form4_1774037666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000004/wk-form4_1774037666.xml","form_type":"4"}},{"id":923414,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:13.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034632/ownership.xml","form_type":"4"}},{"id":950267,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:35:05.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":506250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option will vest on January 2, 2027 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":506250,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":506250},"source":{"system":"sec-edgar","filing":"0001553179-26-000002","document":"wk-form4_1767648900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000002/wk-form4_1767648900.xml","form_type":"4"}},{"id":950266,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2026-01-05T21:35:05.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":84500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in four equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":814061,"source":{"system":"sec-edgar","filing":"0001553179-26-000002","document":"wk-form4_1767648900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317926000002/wk-form4_1767648900.xml","form_type":"4"}},{"id":1026556,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2025-10-02T20:13:38.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":710934,"source":{"system":"sec-edgar","filing":"0001553179-25-000004","document":"wk-form4_1759436015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000155317925000004/wk-form4_1759436015.xml","form_type":"4"}},{"id":1219120,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-06T21:08:00.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":440000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":440000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0001728117-25-000015","document":"wk-form4_1741295273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811725000015/wk-form4_1741295273.xml","form_type":"4"}},{"id":1286298,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:23:44.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-013728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013728/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1286297,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T22:23:44.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":84130,"source":{"system":"sec-edgar","filing":"0000950170-25-013728","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013728/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1288405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-03T16:32:54.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":1.73,"value":62107.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.73,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-012094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025012094/ownership.xml","form_type":"4"}},{"id":1288404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-03T16:32:54.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":84130,"source":{"system":"sec-edgar","filing":"0000950170-25-012094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025012094/ownership.xml","form_type":"4"}},{"id":1558214,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2024-03-28T22:16:41.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":6430,"price":1.1555,"value":7429.865,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.1551 to $1.1626 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":585934,"source":{"system":"sec-edgar","filing":"0001728117-24-000041","document":"wk-form4_1711664190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811724000041/wk-form4_1711664190.xml","form_type":"4"}},{"id":1675840,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-20T02:05:33.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":83685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":83685,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":83685},"source":{"system":"sec-edgar","filing":"0001209191-24-001982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001982/doc4.xml","form_type":"4"}},{"id":1675839,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-20T02:05:33.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":13948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 19, 2025."}],"balance_after":66180,"source":{"system":"sec-edgar","filing":"0001209191-24-001982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001982/doc4.xml","form_type":"4"}},{"id":1687026,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:08:12.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001728117-24-000008","document":"wk-form4_1704406067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811724000008/wk-form4_1704406067.xml","form_type":"4"}},{"id":1730797,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-23T00:07:02.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001728117-23-000144","document":"wk-form4_1700698009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000144/wk-form4_1700698009.xml","form_type":"4"}},{"id":1822691,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock Purchase Warrants","published_at":"2023-07-26T20:01:41.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":3376,"price":0.125,"value":422.0,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":3376,"derivative":{"exercise_price":2.04,"exercise_date":"2023-07-24","expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":3376},"source":{"system":"sec-edgar","filing":"0001728117-23-000098","document":"wf-form4_169040168831720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000098/wf-form4_169040168831720.xml","form_type":"4"}},{"id":1822690,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2023-07-26T20:01:41.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":13504,"price":1.82,"value":24577.28,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":45892,"source":{"system":"sec-edgar","filing":"0001728117-23-000098","document":"wf-form4_169040168831720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000098/wf-form4_169040168831720.xml","form_type":"4"}},{"id":1899203,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 126,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":126667,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899202,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899201,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":47667,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899200,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 70,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":70000,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899199,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":190000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 126,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899198,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.79,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899197,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":71500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1899196,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:18:40.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 70,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.1,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001728117-23-000055","document":"wf-form4_168366350375181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000055/wf-form4_168366350375181.xml","form_type":"4"}},{"id":1941242,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T21:19:06.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":157500,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001728117-23-000022","document":"wf-form4_167951991888150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000022/wf-form4_167951991888150.xml","form_type":"4"}},{"id":1941241,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2023-03-22T21:19:06.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":18500,"price":1.197,"value":22144.5,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":32388,"source":{"system":"sec-edgar","filing":"0001728117-23-000022","document":"wf-form4_167951991888150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811723000022/wf-form4_167951991888150.xml","form_type":"4"}},{"id":2080347,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-20T22:22:35.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":77160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":77160,"derivative":{"exercise_price":2.74,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":77160},"source":{"system":"sec-edgar","filing":"0001209191-22-062192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062192/doc4.xml","form_type":"4"}},{"id":2080346,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T22:22:35.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":38580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 16, 2023."}],"balance_after":52232,"source":{"system":"sec-edgar","filing":"0001209191-22-062192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062192/doc4.xml","form_type":"4"}},{"id":2090805,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T22:17:41.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on December 7, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":157500,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001728117-22-000108","document":"wf-form4_167062422822547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811722000108/wf-form4_167062422822547.xml","form_type":"4"}},{"id":2206797,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2022-07-15T20:25:33.000Z","date":"2022-07-15","kind":"purchase","acquired":true,"shares":6934,"price":7.21,"value":49994.14,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,934 shares, with the Reporting Person's sale of 6,934 shares of common stock at a price of $8.915 per share on March 23, 2022. The Reporting Person paid to the Issuer $11,882.47, representing the full amount of the profit realized in connection with the short-swing transaction."}],"balance_after":13888,"source":{"system":"sec-edgar","filing":"0001728117-22-000063","document":"wf-form4_165791671885890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811722000063/wf-form4_165791671885890.xml","form_type":"4"}},{"id":2318628,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Tech Ops and Admin"}}],"security":"Common Stock","published_at":"2022-03-24T20:57:40.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":10722,"price":8.915,"value":95586.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":579008,"source":{"system":"sec-edgar","filing":"0001728117-22-000033","document":"wf-form4_164815543637815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811722000033/wf-form4_164815543637815.xml","form_type":"4"}},{"id":2438673,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T21:07:32.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":190000,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001728117-22-000005","document":"wf-form4_164184879849201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811722000005/wf-form4_164184879849201.xml","form_type":"4"}},{"id":2460249,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T23:58:53.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":20903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":20903,"derivative":{"exercise_price":9.81,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":20903},"source":{"system":"sec-edgar","filing":"0001209191-21-071172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071172/doc4.xml","form_type":"4"}},{"id":2460248,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T23:58:53.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":10452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were granted as restricted stock units which vest in full on December 22, 2022."}],"balance_after":13652,"source":{"system":"sec-edgar","filing":"0001209191-21-071172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071172/doc4.xml","form_type":"4"}},{"id":2460247,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T23:58:53.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":300,"price":9.7345,"value":2920.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":3200,"source":{"system":"sec-edgar","filing":"0001209191-21-071172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071172/doc4.xml","form_type":"4"}},{"id":2561300,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:30:23.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":300,"price":12.3065,"value":3691.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $12.15 to $12.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001209191-21-057420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121057420/doc4.xml","form_type":"4"}},{"id":2659675,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T21:06:13.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":300,"price":15.1973,"value":4559.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $14.89 to $15.42. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-21-042433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121042433/doc4.xml","form_type":"4"}},{"id":2747759,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-17T00:59:36.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":300,"price":17.5126,"value":5253.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $17.295 to $17.69. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001209191-21-027119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121027119/doc4.xml","form_type":"4"}},{"id":2771683,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-03-25T20:09:29.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":5490,"price":9.481,"value":52050.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":588199,"source":{"system":"sec-edgar","filing":"0001728117-21-000029","document":"wf-form4_161670295456273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811721000029/wf-form4_161670295456273.xml","form_type":"4"}},{"id":2825404,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T21:37:18.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option will vest on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":90000,"derivative":{"exercise_price":9.79,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001728117-21-000021","document":"wf-form4_161463460466974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811721000021/wf-form4_161463460466974.xml","form_type":"4"}},{"id":2825403,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T21:37:18.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 97,923 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Also includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":593689,"source":{"system":"sec-edgar","filing":"0001728117-21-000021","document":"wf-form4_161463460466974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000172811721000021/wf-form4_161463460466974.xml","form_type":"4"}},{"id":2933800,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:21:56.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":19.46,"expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-065012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065012/doc4.xml","form_type":"4"}},{"id":2933799,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T21:21:56.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in four equal quarterly installments beginning three months after the date of grant."}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001209191-20-065012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065012/doc4.xml","form_type":"4"}},{"id":3006588,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-15T20:21:10.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in two equal monthly installments beginning one month after the date of grant."}],"balance_after":437,"derivative":{"exercise_price":15.72,"expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":437},"source":{"system":"sec-edgar","filing":"0001209191-20-054906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054906/doc4.xml","form_type":"4"}},{"id":3006841,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-10-14T23:29:57.000Z","date":"2020-10-14","kind":"purchase","acquired":true,"shares":2500,"price":9.5272,"value":23818.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $9.52 to $9.53 per share. The price reported above reflects the\nweighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price\ncan be obtained from the Issuer upon request."}],"balance_after":6954,"source":{"system":"sec-edgar","filing":"0001209191-20-054842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919120054842/doc4.xml","form_type":"4"}},{"id":3174723,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-18T01:08:15.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in eight equal monthly installments beginning one month after the date of grant."}],"balance_after":713,"derivative":{"exercise_price":14.44,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":713},"source":{"system":"sec-edgar","filing":"0001209191-20-025021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120025021/doc4.xml","form_type":"4"}},{"id":3262108,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:21:06.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":71500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option will vest on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":71500,"derivative":{"exercise_price":14.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001209191-20-010517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919120010517/doc4.xml","form_type":"4"}},{"id":3262107,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-02-19T21:21:06.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 228,459 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":547998,"source":{"system":"sec-edgar","filing":"0001209191-20-010517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919120010517/doc4.xml","form_type":"4"}},{"id":3333110,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-23T21:24:59.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":25.02,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-19-061789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119061789/doc4.xml","form_type":"4"}},{"id":3405084,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2019-09-27T14:46:33.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":1000,"price":16.6542,"value":16654.2,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $16.63 to $16.69 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request."}],"balance_after":4454,"source":{"system":"sec-edgar","filing":"0001209191-19-050930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919119050930/doc4.xml","form_type":"4"}},{"id":3524847,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T12:44:44.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":1400,"price":18.0441,"value":25261.74,"ownership":{"direct":true},"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001209191-19-030201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119030201/doc4.xml","form_type":"4"}},{"id":3578100,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-26T22:49:55.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 25, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":105000,"derivative":{"exercise_price":22.1,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-19-021365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919119021365/doc4.xml","form_type":"4"}},{"id":3662450,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Series B Preferred Stock","published_at":"2019-02-12T22:36:54.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":15543,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001209191-19-009441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919119009441/doc4.xml","form_type":"4"}},{"id":3662449,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2019-02-12T22:36:54.000Z","date":"2019-02-12","kind":"purchase","acquired":true,"shares":1550,"price":16,"value":24800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 369,871 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Corporation on each such vesting date. The shares are also subject to certain accelerated vesting provisions as set forth in more detail in the employment agreement between the Issuer and the Reporting Person."}],"balance_after":501498,"source":{"system":"sec-edgar","filing":"0001209191-19-009441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919119009441/doc4.xml","form_type":"4"}},{"id":3662448,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2019-02-12T22:36:54.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":3454,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."}],"balance_after":3454,"source":{"system":"sec-edgar","filing":"0001209191-19-009441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553179/000120919119009441/doc4.xml","form_type":"4"}},{"id":3728047,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-19T01:06:48.000Z","date":"2018-12-15","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":24.97,"expiration_date":"2028-12-15","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-18-063348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118063348/doc4.xml","form_type":"4"}},{"id":4125521,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-20T21:18:49.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":17,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-066635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117066635/doc4.xml","form_type":"4"}},{"id":4356404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-07T20:28:25.000Z","date":"2017-04-05","kind":"grant","acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in nine equal monthly installments beginning one month after the date of grant."}],"balance_after":1125,"derivative":{"exercise_price":13.5,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001209191-17-026256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117026256/doc4.xml","form_type":"4"}},{"id":4512841,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-23T21:08:09.000Z","date":"2016-12-21","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":15500,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-16-156667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919116156667/doc4.xml","form_type":"4"}}]}